Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Vaxil Bio Ltd.
  6. News
  7. Summary
    VXL   CA92243L1076

VAXIL BIO LTD.

(VXL)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

David Goren Resigns as Chief Executive Officer of Vaxil Bio Ltd

05/05/2021 | 03:23pm EDT

VAXIL BIO LTD. announced that Mr. David Goren has provided notice that he will be resigning as the company's chief executive officer ("CEO") to pursue other opportunities. The resignation will take effect on August 1, 2021 (the "Effective Date"). Mr. Goren has agreed that until the Effective Date, he will, in addition to continuing to fulfill his responsibilities as CEO, assist the company's board of directors ("Board") in their search for a new CEO, which has already commenced.


ę S&P Capital IQ 2021
All news about VAXIL BIO LTD.
08/30Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter Ended June 30,..
CI
08/04VAXIL BIO : Names Avnir as Interim Chief Executive as Goren Departs
MT
08/04Vaxil Bio Ltd. Appoints Yuval Avnir as Interim Chief Executive Officer
CI
08/04VAXIL BIO : Announces Changes to Senior Management and Provides Updates on Curre..
AQ
08/04Vaxil Bio Ltd. Announces Executive Changes
CI
05/31Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/31UPDATE : Vaxil Down Near 5% as Provides Research and Development Update
MT
05/31VAXIL BIO : Provides Research and Development Update
AQ
05/05VAXIL BIO : Announces CEO Resignation
AQ
05/05David Goren Resigns as Chief Executive Officer of Vaxil Bio Ltd
CI
More news
Financials
Sales 2020 - - -
Net income 2020 -1,36 M -1,06 M -1,06 M
Net cash 2020 1,50 M 1,17 M 1,17 M
P/E ratio 2020 -22,5x
Yield 2020 -
Capitalization 9,56 M 7,50 M 7,44 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 91,5%
Chart VAXIL BIO LTD.
Duration : Period :
Vaxil Bio Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VAXIL BIO LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Yuval Avnir Chief Executive Officer
Gadi Levin Chairman & Chief Financial Officer
Terry F. Plasse Chief Medical Officer
Ari S. Kellen Independent Director
Shawn Langer Independent Director
Sector and Competitors
1st jan.Capi. (M$)
VAXIL BIO LTD.-76.67%8
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420